|
|
|
Roche and BioLamina Collaborate on Novel Cell Culture Systems
Roche and BioLamina have entered into a research and development agreement to jointly develop new cell culture systems for various applications, including stem cell research. The collaboration will assess laminin-based in vitro cell culture matrices that can offer physiological microenvironments for living cells. More... |
|
|
First Biologic Approved in the EU for Gouty Arthritis
Ilaris (canakinumab), a selective, fully human, monoclonal antibody that inhibits interleukin-1 beta (IL-1 beta), has been approved in the EU for symptomatic pain relief in patients suffering from gouty arthritis whose condition cannot be managed with current treatments. More... |
|
|
|
|
|
|
Agilent |
Together: It’s how we help Pharma Succeed
Agilent QC solutions help simplify complexities for highest reproducibility from lab to lab, around the world. The Agilent 1290 Infinity LC with ISET enables secure method transfer between different U/HPLC instruments, with one click. CrossLab Services can reduce downtime for all instruments, regardless of manufacturer. “Fast LC” column choices help you get the most from every instrument. See more at www.agilent.com/chem/togetherQC |
 |
|
Shimadzu |
Eliminate Ghost Peaks in UHPLC
Shimadzu has introduced the Ghost Trap™ DS-HP Series Columns which are designed to remove impurities from the solvent and system, enabling highly sensitive and reliable analysis. Read more |
 |
|
|
Roquette Pharma |
Coating heat-sensitive products at ambient temperature
See how LYCOAT® / ReadiLYCOAT® can be applied to your heat-sensitive ingredients or dosage forms at the same time as keeping the coating process short and providing an inert coating of perfect quality. And that’s not all.... Read more |
 |
|
|
|
|
|
What do you think is the main challenge facing manufacturers seeking to launch a new biosimilar? |
|
Safety and interchangeability concerns |
36% |
|
|
Regulatory processes |
28% |
|
|
|
|
Legal challenges |
9% |
|
|
|
|
Complex manufacturing processes |
27% |
This week we would like to know...
How do you think the reputation of the pharmaceutical industry has changed in recent years?

|
|
|
Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|